Transmedics Group Inc reports results for the quarter ended March 31 - Earnings Summary

• Transmedics Group Inc TMDX.OQ reported quarterly adjusted earnings of 70 cents​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of 35 cents. The mean expectation of ten analysts for the quarter was for earnings of 26 cents per share. Wall Street expected results to range from 12 cents to 34 cents per share.

• Revenue rose 48.2% to $143.54 million from a year ago; analysts expected $123.66 million.

• Transmedics Group Inc's reported EPS for the quarter was 70 cents​.

• The company reported quarterly net income of $25.68 million.

• Transmedics Group Inc shares had risen by 42.4% this quarter and gained 53.7% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 5.3% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is also "buy"

• Wall Street's median 12-month price target for Transmedics Group Inc is $112.50

This summary was machine generated from LSEG data May 8 at 09:01 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)